DP Technology (深势科技)
Beijing AI-for-science company built on "AI for molecular simulation" — open-source DeePMD potentials plus a scientific-computing cloud, with Weinan E as scientific co-founder.
1. Core Product / Service
DP Technology (深势科技) applies machine-learned interatomic potentials to molecular dynamics, with its research lineage in DeePMD-kit (deep potential molecular dynamics), an open-source framework widely used in computational chemistry and materials (see mattersim for the related MLIP lineage). Its commercial products include Bohrium (玻尔), a scientific-computing cloud/workbench, and Hermite, a drug-design platform built on the same simulation engine [local]. "玻尔·科学导航" is reported to serve 3M+ researchers across 1,000+ universities and institutions [pedaily 2025-12].
It has also moved down into the wet lab with Uni-Lab-OS, an open-source lab operating system that already connects 100+ instrument models, pitched as the "Android of AI4S" for a read–compute–do loop [local].
2. Target Users & Pain Points
- Research institutions and industrial R&D (chemistry, materials, pharma) needing ab-initio-accuracy simulation at a fraction of first-principles cost.
- Pain solved: classical molecular dynamics is fast but inaccurate; first-principles DFT is accurate but slow — machine-learned potentials offer DFT-level accuracy at MD speed, a step change for screening and simulation.
3. Competitive Landscape
| Player | Positioning | Vs. DP Technology |
|---|---|---|
| xtalpi | CSP + AI drug discovery (China, listed) | XtalPi is drug-discovery-vertical; DP is simulation-infra horizontal |
| insilico-medicine | Generative-AI biotech | Different method (generative design vs. simulation) |
| mattersim | Open MLIP model (Microsoft) | DP is a company; Mattersim is an open model |
| Schrödinger / Dassault (BIOVIA) | Computational chemistry incumbents | DP is MLIP-native, cloud-first |
4. Unique Observations
- China's AI4S flagship: earlier research positioned 深势科技 as China's leading AI-for-science company, led by a 院士-grade scientific team — the domestic counterpart to the US isomorphic-labs/google-deepmind axis [local].
- Method → infra → vertical: DP's path from open-source method (DeePMD) to cloud platform (Bohrium) to vertical app (Hermite drug design) mirrors how US AI4S players monetize research, and fits the "serve AI4S companies" platform-opportunity thesis [local].
- Platform threat to lab integrators: if the lab-OS layer standardizes on an open-source stack like Uni-Lab-OS, hardware integrators such as megarobo lose their software premium and compete on delivery alone [local].
- Academic-founder advantage: Weinan E (鄂维南, applied mathematician, Princeton professor, CAS academician) gives it top-tier scientific credibility for talent and customer trust in China.
5. Financials / Funding
- Seed grant (2019): RMB 12M from a Zhongguancun disruptive-technology programme (disbursed over 3 years) [local].
- Angel (summer 2020): led by Baidu Ventures, with 唯猎资本 and 盛景嘉成 participating [local].
- Pre-A (Mar 2021): led by 元璟资本, with 清流资本 participating [local].
- Series A (Aug 2021): tens of millions of USD, led by Hillhouse (GL Ventures), with Matrix Partners China and 元璟资本 [local].
- Series B (Jan 2022): tens of millions of USD, led by Source Code Capital and Qiming, with Hillhouse and Matrix following [local].
- Series B+ (Aug 2023): > RMB 700M; investors include 众源资本, 和玉资本, 正心谷, Hubble (Huawei), Evergreen Scitech Delta and Su Hua [local].
- Series B++ (Oct 2024): several hundred million RMB from the Beijing AI Industry Investment Fund and Zhongguancun Science City [local].
- Series C (Dec 2025): > RMB 800M, from Fortune Capital (达晨), Jingguorui fund, Beijing AI Industry Investment Fund, Beijing Pharma & Health Fund, Legend Capital, Yuanhe Puhua [pedaily]. Post-money valuation reported at > RMB 6B [local].
- Total: roughly seven priced rounds totalling several billion RMB, with a high share of Beijing state-backed capital [local].
- Status (Oct 2026): completed joint-stock conversion (now 北京深势科技股份有限公司) around Feb 2026, preparing a Hong Kong IPO billed as "China's first AI4S stock"; no HKEX filing found as of 2026-10-12 (single-source report on the conversion).
6. People & Relationships
- Scientific co-founder: 鄂维南 (Weinan E) — applied mathematician, Princeton professor, CAS academician; co-founded with 张林峰 (Zhang Linfeng) and 孙伟杰 (Sun Weijie).
- Investors (selected): Baidu Ventures, Hillhouse (GL Ventures), Matrix Partners China, Source Code Capital, Qiming, Hubble (Huawei), Fortune Capital, Legend Capital, Beijing AI Industry Investment Fund [local].
- Peers: xtalpi, insilico-medicine, mattersim.